Building Automated Pharmacometrics Analysis Workflows in R with NMsim Poster Building Automated Pharmacometrics Analysis Workflows in R with NMsim CertaraNovember 22, 2024
Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Potential Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Mixed Hyperlipidemia Poster Population K-PD Modeling of Plozasiran (ARO-APOC3), a GalNAc-siRNA Conjugate, for the Potential Treatment of Atherosclerotic Cardiovascular Disease (ASCVD) in Patients with Mixed Hyperlipidemia CertaraNovember 22, 2024
Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites Poster Integrated Population Pharmacokinetic Model of Bemnifosbuvir and Metabolites CertaraNovember 22, 2024
Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10) Poster Indirect Exposure-Response Modeling for Transthyretin Amyloid Cardiomyopathy Treated with Acoramidis (AG10) CertaraNovember 22, 2024
Towards Predicting Individual Cognitive Trajectories in Alzheimer’s Disease using Quantitative Systems Pharmacology Poster Towards Predicting Individual Cognitive Trajectories in Alzheimer’s Disease using Quantitative Systems Pharmacology About Functional readouts in Alzheimer's Disease is highly variable due to different comedications, genotypes, amyloid-…CertaraNovember 22, 2024
Effects of Anti-Amyloid Treatment on Tau Biomarkers and Functional Outcome Poster Effects of Anti-Amyloid Treatment on Tau Biomarkers and Functional Outcome About There are major unaddressed issues in Alzheimer's Disease clinical practice such as: Identifying accessible…CertaraNovember 22, 2024
A Mechanistic PK/PD Model for First-in-Human Dosing of a Tetraspecific Antibody (MDX2001) for the Treatment of Advanced Solid Tumors Poster A Mechanistic PK/PD Model for First-in-Human Dosing of a Tetraspecific Antibody (MDX2001) for the Treatment of Advanced Solid Tumors MDX2001 is a tetraspecific T cell engager that binds CD3 and CD28 on T cells…CertaraNovember 22, 2024
Augmented Definitive Screening Design Provides Efficient Phase 1 Selection of CAR T-cell and Lymphodepletion Regimen Poster Augmented Definitive Screening Design Provides Efficient Phase 1 Selection of CAR T-cell and Lymphodepletion Regimen CertaraNovember 22, 2024
Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials Poster Oncology MIDD Simulator, A User-Friendly Application for Overall Survival Forecasting in Early Oncology Trials CertaraNovember 22, 2024
Population pharmacokinetic modeling of niraparib to assess different absorption models Poster Population pharmacokinetic modeling of niraparib to assess different absorption models CertaraNovember 22, 2024